High post-challenge glucose plasma concentrations that are observed during pregnancy screening can help to identify women who are at an increased likelihood of later health issues, predominantly cardiovascular diseases. This finding offers a unique opportunity to improve the health of women, but further work is required to translate into clinical benefits.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kramer, C. K., Campbell, S. & Retnakaran, R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia https://doi.org/10.1007/s00125-019-4840-2 (2019).
Retnakaran, R. & Shah, B. R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. Can. Med. Assoc. J. 181, 371–376 (2009).
Retnakaran, R. & Shah, B. R. Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 7, 378–384 (2019).
Albareda, M. et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26, 1199–1205 (2003).
Anastasiou, E. et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21, 2111–2115 (1998).
Coutinho, M. et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 22, 233–240 (1999).
McKinney, J. et al. ACOG Committee Opinion no. 736: Optimizing postpartum care. Obstet. Gynecol. 132, 784–785 (2018).
Casey, B. M. et al. Effect of treatment of mild gestational diabetes on long-term maternal outcomes. Am. J. Perinatol. https://doi.org/10.1055/s-0039-1681058 (2019).
Diabetes Prevention Program Research Group. Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care 42, 601–608 (2019).
Goveia, P. et al. Lifestyle intervention for the prevention of diabetes in women with previous gestational diabetes mellitus: a systematic review and meta-analysis. Front. Endocrinol. 9, 583 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.C. declares no competing interests.
Rights and permissions
About this article
Cite this article
Corcoy, R. Glucose screening in pregnancy to predict future cardiovascular risk. Nat Rev Endocrinol 15, 380–382 (2019). https://doi.org/10.1038/s41574-019-0216-4
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41574-019-0216-4
